/
FDA warns that SGLT2 inhibitors for diabetes may result in a serious c FDA warns that SGLT2 inhibitors for diabetes may result in a serious c

FDA warns that SGLT2 inhibitors for diabetes may result in a serious c - PDF document

debby-jeon
debby-jeon . @debby-jeon
Follow
387 views
Uploaded On 2015-12-04

FDA warns that SGLT2 inhibitors for diabetes may result in a serious c - PPT Presentation

DKA a subset of ketoacidosis or ketosis in diabetic patients is atype of acidosis that sually develops when insulin levels are too low or during prolonged fasting DKA most commonly occurs in patie ID: 214021

DKA subset ketoacidosis

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "FDA warns that SGLT2 inhibitors for diab..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript